Please login to the form below

Not currently logged in
Email:
Password:

BI

This page shows the latest BI news and features for those working in and with pharma, biotech and healthcare.

Boehringer’s IL-36-targeting drug tackles rare form of psoriasis

Boehringer’s IL-36-targeting drug tackles rare form of psoriasis

Jan Poth. For Boehringer, the successful study in GPP bodes well for BI 655130’s potential in other immune diseases, including more common indications including inflammatory bowel disease. ... Trials of BI 655130 are also underway in palmoplantar

Latest news

More from news
Approximately 4 fully matching, plus 87 partially matching documents found.

Latest Intelligence

  • The ‘Million Hour Challenge’ The ‘Million Hour Challenge’

    Since the initiative launched, AstraZeneca has seen two consecutive increases in the bi-annual employee engagement survey, with 69% of AstraZeneca employees agreeing that ‘Together, we are making progress in our

  • Is it time we stopped talking about adherence? Is it time we stopped talking about adherence?

    attractive and valuable bi-product.

  • Deal Watch September 2016 Deal Watch September 2016

    Boehringer Ingelheim granted Amgen worldwide rights to BI 836909, a bispecific T cell engager designed to treat multiple myeloma. ... Under the agreement, Daiichi Sankyo will acquire a licence to Zymeworks' platforms to develop a bi-specific antibody

  • The human perspective The human perspective

    But you can deal with the other three factors. This is where Boehringer has a key strength because there is a very, very strong culture, which is built on our BI

  • Deal Watch April 2016 Deal Watch April 2016

    1, 200. ZymeWorks (US). GSK (UK). License and option. Preclinical bi-specific antibodies based on Azymetric platform for treatment of solid tumours.

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest from PMHub

  • EphMRA Annual Conference 2018

    In this paper, Ursula and Angela will show how they worked together on an initiative which would challenge the BI team’s comfort levels and capabilities, but ultimately elevate customer insights

  • Box Bear Ltd

    A boutique agency punching above its weight. Prefered suppliers of GSK, Roche, Shire and BI to name a few, working directly or with partners to deliver animation, video, webinars, AR and

  • Frontera Group

    Gold - Caphosol sales aid - Sales aid. Gold - BI interactive video - Interactive communications.

  • Infographic: HIV Market Snapshot

    Therapy Watch HIV patient data is collected bi-monthly from a panel of 150 physicians across the main 5 EU markets and 100 physicians in the US.

  • Delivering successful international business intelligence

    He also discusses the approach of configuring a Pharma-specific BI Platform and SaaS solutions as well as touching on hosting choices. .

More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics